Compound | Tanimoto | Log Pa | Percent activityb | IC50 |
---|---|---|---|---|
L254614 | 1.441 | 3.264 | 3 | 0.15 |
9009967 | 1.436 | 3.465 | 25 | 0.71 |
002-126-168 | 1.344 | 4.359 | 8 | 0.67 |
016-629-555 | 1.484 | 3.259 | 18 | 0.61 |
020-139-730 | 1.423 | 2.899 | 56 | 2.38 |
Z1006910000 | 1.389 | 2.672 | 61 | 3.1 |
9291732 | 1.360 | 2.717 | 53 | 1.74 |
ADM19808287 | 1.389 | 2.371 | 68 | N/D |
004-430-932 | 1.423 | 3.406 | 67 | N/D |
Z66113547 | 1.353 | 3.403 | 77 | N/D |
004-212-014 | 1.420 | 2.862 | 83 | N/D |
Z219193164 | 1.400 | 0.959 | 93 | N/D |
Z131771408 | 1.353 | 2.316 | 87 | N/D |
004-301-433 | 1.352 | −0.162 | 95 | N/D |
004-212-014, 1-(4-fluorophenyl)-4-[3-(4-fluorophenyl)imidazole-4-carbonyl]piperazine; 004-301-433, 2-[4-(1H-imidazol-1-ylmethyl)phenyl]benzoic acid; 004-430-932, 1-(3-phenylimidazole-4-carbonyl)-4-[3-(trifluoromethyl)phenyl]piperazine; 016-629-555, 1-[4′-(1H-imidazol-1-ylmethyl)biphenyl-3-yl]ethanone; 020-139-730, 5-(imidazol-1-ylmethyl)-4-methyl-2-phenyl-1,3-thiazole; 9009967, 1-{2-[(1-chloro-2-naphthyl)oxy]ethyl}-1H-imidazole hydrochloride; 9291732, 1-[4-(1H-imidazol-1-ylmethyl)benzoyl]indoline; ADM19808287, (3S)-3-imidazol-1-yl-1-[4-[3-methyl-4-(trifluoromethyl) isoxazole[4,5-e]pyridin-6-yl]-1-piperidyl]but; Z1006910000, (2S)-2-imidazol-1-yl-N-methyl-N-[2-(1-naphthyl)ethyl]propanamide; Z131771408, N-[(1-benzylpyrazol-4-yl)methyl]-N-methyl-3-phenyl-imidazole-4-carboxamide; Z219193164, [4-(imidazol-1-ylmethyl)phenyl]-pyrrolidin-1-yl-methanone; Z66113547, 3-(4-fluorophenyl)-N-methyl-N-[[4-(trifluoromethyl)phenyl]methyl]imidazole-4-carboxamide.
↵a Log P is calculated using Molinspiration online cheminformatics tools.
↵b Percent activity at 2:1 compound to cyt c ratio is displayed.